Open Access
CC BY 4.0 · Endosc Int Open 2025; 13: a26812538
DOI: 10.1055/a-2681-2538
Original article

Transoral incisionless fundoplication for patients with gastroesophageal reflux disease after peroral endoscopic myotomy: Prospective cohort

1   Gastrointestinal Endoscopy Unit, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
,
1   Gastrointestinal Endoscopy Unit, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
,
1   Gastrointestinal Endoscopy Unit, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
,
1   Gastrointestinal Endoscopy Unit, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
,
Antonio Afonso Miranda Neto
1   Gastrointestinal Endoscopy Unit, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
,
Eduardo Turiani Hourneaux de Moura
1   Gastrointestinal Endoscopy Unit, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
,
André Orsini Ardengh
2   Surgery, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil (Ringgold ID: RIN37870)
,
Ary Nasi
1   Gastrointestinal Endoscopy Unit, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
,
Kenneth Chang
3   Medicine, University of California Irvine, Irvine, United States (Ringgold ID: RIN8788)
,
1   Gastrointestinal Endoscopy Unit, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
4   USP, Universidade de São Paulo Faculdade de Medicina, São Paulo, Brazil (Ringgold ID: RIN37884)
› Author Affiliations
Clinical Trial: Registration number (trial ID): 81178623.0.0000.0068, Trial registry: Brazilian Clinical Trials Registry (http://www.ensaiosclinicos.gov.br/), Type of Study: Prospective
Preview

Abstract

Background and study aims

Achalasia is a condition related to failure of relaxation of the lower esophageal sphincter (LES). Treatment is based on reducing LES pressure. Although treatment is traditionally surgical, poor candidates for this modality may be treated with peroral endoscopic myotomy (POEM). However, POEM is associated with a relatively high incidence of gastroesophageal reflux disease (GERD). For cases refractory to proton pump inhibitors (PPIs), transoral incisionless fundoplication (TIF) is one of the endoscopic therapies proposed.

Patients and methods

This was a pilot single-center prospective cohort study including 10 patients with post-POEM GERD refractory to clinical management who underwent endoscopic treatment with the TIF procedure between February and November 2021. We included patients ≥ 18 years old who developed GERD after POEM.

Results

Technical success was achieved in all 10 cases treated with TIF. In 6- and 12-month follow-up, seven patients (70%) reduced PPI use. Two patients (20%) had no esophagitis initially, increasing to five (55%) at 6 months and four (44%) at 12 months. Symptom evaluation and GERD-HRQL questionnaire showed a significant score reduction at 6 months and a downward trend at 12 months. Mean Eckardt score showed a decreasing trend, although mean dysphagia score showed a slight tendency to increase in 1 year. The procedure was considered safe, with no adverse events.

Conclusions

Use of TIF seems to be a feasible alternative for treating GERD after POEM, improving both clinical and endoscopic parameters and pHmetry in a considerable percentage of cases.



Publication History

Received: 19 September 2024

Accepted after revision: 24 July 2025

Accepted Manuscript online:
11 August 2025

Article published online:
01 September 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Bibliographical Record
Eduardo Guimarães Hourneaux de Moura, Matheus Ferreira de Carvalho, Victor Lira de Oliveira, Mateus Bond Boghossian, Antonio Afonso Miranda Neto, Eduardo Turiani Hourneaux de Moura, André Orsini Ardengh, Ary Nasi, Kenneth Chang, Mateus Pereira Funari. Transoral incisionless fundoplication for patients with gastroesophageal reflux disease after peroral endoscopic myotomy: Prospective cohort. Endosc Int Open 2025; 13: a26812538.
DOI: 10.1055/a-2681-2538
 
  • References

  • 1 Hasan A, Low EE, Fehmi SA. et al. Evolution and evidence-based adaptations in techniques for peroral endoscopic myotomy for achalasia. Gastrointest Endosc 2022; 96: 189-196
  • 2 Repici A, Fuccio L, Maselli R. et al. GERD after per-oral endoscopic myotomy as compared with Heller’s myotomy with fundoplication: a systematic review with meta-analysis. Gastrointest Endosc 2018; 87: 934-943 e18
  • 3 Tassi V, Lugaresi M, Pilotti V. et al. Outcomes of Heller myotomy for esophageal achalasia: Lessons from a 48-year prospective experience with 4 different techniques. Ann Surg 2023; 278: e27-e34
  • 4 Conte TM, Haddad LB de P, Ribeiro IB. et al. Peroral endoscopic myotomy (POEM) is more cost-effective than laparoscopic Heller myotomy in the short term for achalasia: economic evaluation from a randomized controlled trial. Endosc Int Open 2020; 8: E1673-E1680
  • 5 Ujiki MB, VanDruff VN. Peroral endoscopic myotomy for achalasia. World J Surg 2022; 46: 1542-1546
  • 6 Kum AS-T, De Moura DTH, Proença IM. et al. Gastroesophageal reflux waning over time in endoscopic versus surgical myotomy for the treatment of achalasia: A systematic review and meta-analysis. Cureus 2022; 14: e31756
  • 7 de Moura ETH, Jukemura J, Ribeiro IB. et al. Peroral endoscopic myotomy vs laparoscopic myotomy and partial fundoplication for esophageal achalasia: A single-center randomized controlled trial. World J Gastroenterol 2022; 28: 4875-4889
  • 8 Martins RK, Ribeiro IB, de Moura DTH. et al. Peroral (POEM) or surgical myotomy for the treatment of achalasia: a systematic review and meta-analysis. Arq Gastroenterol 2020; 57: 79-86
  • 9 Mota RCL, de Moura EGH, de Moura DTH. et al. Risk factors for gastroesophageal reflux after POEM for achalasia: a systematic review and meta-analysis. Surg Endosc 2021; 35: 383-397
  • 10 Zhang H, Zeng X, Huang S. et al. Mid-term and long-term outcomes of peroral endoscopic myotomy for the treatment of achalasia: A systematic review and meta-analysis. Dig Dis Sci 2023; 68: 1386-1396
  • 11 Teh JL, Tham HY, Soh AY. et al. Gastro-esophageal reflux disease (GERD) after peroral endoscopic myotomy (POEM). Surg Endosc 2022; 36: 3308-3316
  • 12 Zaninotto G, Rizzetto C, Zambon P. et al. Long-term outcome and risk of oesophageal cancer after surgery for achalasia. Br J Surg 2008; 95: 1488-1494
  • 13 Nagi TK, Suarez ZK, Haider MA. et al. Per-oral endoscopic myotomy-induced gastroesophageal reflux disease and review of the efficacy of proton pump inhibitors as a management strategy: Review of the literature. Cureus 2023; 15: E50324
  • 14 Inoue H, Shiwaku H, Kobayashi Y. et al. Statement for gastroesophageal reflux disease after peroral endoscopic myotomy from an international multicenter experience. Esophagus 2020; 17: 3-10
  • 15 Perbtani YB, Westerveld DR, Yang DJ. et al. CYP2C19 genotype variability in patients with refractory gastroesophageal reflux after per-oral endoscopic myotomy (POEM). Endosc Int Open 2021; 9: E843-E847
  • 16 Nurczyk K, Farrell TM, Patti MG. Antireflux surgery for gastroesophageal reflux refractory to medical treatment after peroral endoscopic myotomy. J Laparoendosc Adv Surg Tech A 2020; 30: 612-614
  • 17 Richardson WS, Gorham JK, Neal N. et al. Endoscopic treatment of gastroesophageal reflux disease. Adv Surg 2022; 56: 205-227
  • 18 Trad KS, Barnes WE, Prevou ER. et al. The TEMPO Trial at 5 years: Transoral fundoplication (tif 2.0) is safe, durable, and cost-effective. Surg Innov 2018; 25: 149-157
  • 19 Haseeb M, Brown JRG, Hayat U. et al. Impact of second-generation transoral incisionless fundoplication on atypical GERD symptoms: a systematic review and meta-analysis. Gastrointest Endosc 2023; 97: 394-406 e2
  • 20 Zhu X, Shen J. Anti-reflux mucosectomy (ARMS) for refractory gastroesophageal reflux disease. Eur J Med Res 2024; 29: 185
  • 21 Shimamura Y, Inoue H, Tanabe M. et al. Clinical outcomes of anti-reflux mucosal ablation for gastroesophageal reflux disease: An international bi-institutional study. J Gastroenterol Hepatol 2024; 39: 149-156
  • 22 Gyawali CP, Kahrilas PJ, Savarino E. et al. Modern diagnosis of GERD: the Lyon Consensus. Gut 2018; 67: 1351-1362
  • 23 Velanovich V. The development of the GERD-HRQL symptom severity instrument. Dis Esophagus 2007; 20: 130-134
  • 24 Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 1995; 108: 1308-1315
  • 25 Tyberg A, Choi A, Gaidhane M. et al. Transoral incisional fundoplication for reflux after peroral endoscopic myotomy: a crucial addition to our arsenal. Endosc Int Open 2018; 6: E549-E552
  • 26 Brewer Gutierrez OI, Chang KJ, Benias PC. et al. Is transoral incisionless fundoplication (TIF) an answer to post-peroral endoscopic myotomy gastroesophageal reflux? A multicenter retrospective study. Endoscopy 2022; 54: 305-309
  • 27 DeWitt JM, Al-Haddad M, Stainko S. et al. Transoral incisionless fundoplication with or without hiatal hernia repair for gastroesophageal reflux disease after peroral endoscopic myotomy. Endosc Int Open 2024; 12: E43-E49
  • 28 Trad KS, Barnes WE, Simoni G. et al. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial. Surg Innov 2015; 22: 26-40
  • 29 Ayoub F, Keihanian T, Zabad N. et al. The role of transoral incisionless fundoplication (TIF) in the management of gastroesophageal reflux disease (GERD) following peroral endoscopic myotomy (POEM): A pilot, prospective, patient-driven study. Saudi J Gastroenterol 2024; 30: 266-271
  • 30 Testoni PA, Testoni S, Distefano G. et al. Long-term outcomes of transoral incisionless fundoplication for gastro-esophageal reflux disease: systematic-review and meta-analysis. Endosc Int Open 2021; 9: E239-E246
  • 31 Chimukangara M, Jalilvand AD, Melvin WS. et al. Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort study. Surg Endosc 2019; 33: 1304-1309
  • 32 Farias GFA, de Moura DTH, de Moura ETH. et al. Peroral endoscopic myotomy (POEM): a comparative study between Chagasic and idiopathic achalasia. Endosc Int Open 2020; 8: E506-E512
  • 33 Ponds FA, Oors JM, Smout AJPM. et al. Reflux symptoms and oesophageal acidification in treated achalasia patients are often not reflux related. Gut 2021; 70: 30-39
  • 34 Frazzoni M, Conigliaro R, Manta R. et al. Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD. Aliment Pharmacol Ther 2011; 34: 67-75
  • 35 Jaruvongvanich VK, Matar R, Reisenauer J. et al. Hiatal hernia repair with transoral incisionless fundoplication versus Nissen fundoplication for gastroesophageal reflux disease: A retrospective study. Endosc Int Open 2023; 11: E11-E18